David S Goldstein Selected Research

Tachycardia (Tachyarrhythmias)

11/2004	Influence of St John's wort on catecholamine turnover and cardiovascular regulation in humans.
11/2002	Dysautonomias: clinical disorders of the autonomic nervous system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David S Goldstein Research Topics

Disease

78	Parkinson Disease (Parkinson's Disease) 05/2024 - 08/2002
45	Orthostatic Hypotension (Postural Hypotension) 03/2024 - 11/2002
37	Multiple System Atrophy 01/2024 - 07/2002
35	Pure Autonomic Failure 02/2024 - 08/2002
20	Parkinsonian Disorders (Parkinsonism) 12/2022 - 09/2003
20	Synucleinopathies 01/2022 - 02/2007
17	Pheochromocytoma 01/2018 - 03/2002
15	Dementia (Dementias) 12/2023 - 11/2011
15	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2008
12	Neoplasms (Cancer) 01/2010 - 03/2002
10	Movement Disorders (Movement Disorder) 01/2020 - 11/2003
10	Hypertension (High Blood Pressure) 02/2016 - 05/2002
9	Dizziness (Lightheadedness) 01/2024 - 02/2002
8	Autonomic Nervous System Diseases (Dysautonomia) 01/2020 - 06/2003
7	Menkes Kinky Hair Syndrome (Menkes Disease) 09/2018 - 02/2008
6	Lewy Body Disease (Lewy Body Dementia) 01/2018 - 03/2009
5	Anosmia 01/2019 - 01/2010
5	REM Sleep Behavior Disorder 01/2019 - 11/2011
5	Orthostatic Intolerance 01/2019 - 11/2002
4	Cognitive Dysfunction 01/2022 - 04/2011
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 06/2003
3	Heart Failure 03/2022 - 11/2002
3	Syncope (Fainting) 01/2019 - 01/2003
3	Hypothermia 09/2008 - 01/2002
3	von Hippel-Lindau Disease (von Hippel Lindau Disease) 05/2007 - 10/2005
3	Multiple Endocrine Neoplasia Type 2a (MEN 2) 05/2007 - 10/2005
3	Vasovagal Syncope 09/2006 - 06/2002
2	Shock 09/2022 - 09/2006
2	dopamine beta hydroxylase deficiency 01/2019 - 06/2012
2	Neurodevelopmental Disorders 01/2018 - 08/2009
2	Disease Progression 11/2017 - 11/2003
2	Hypotension (Low Blood Pressure) 08/2009 - 09/2006
2	Paraganglioma (Paragangliomas) 04/2005 - 01/2003
2	Tachycardia (Tachyarrhythmias) 11/2004 - 11/2002
2	Schizophrenia (Dementia Praecox) 11/2004 - 08/2002
2	Shy-Drager Syndrome 06/2004 - 07/2002
1	Pneumonia (Pneumonitis) 05/2024
1	Fatigue 02/2024
1	Substance-Related Disorders (Drug Abuse) 09/2022

Drug/Important Bio-Agent (IBA)

44	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2024 - 02/2002
36	CatecholaminesIBA 01/2022 - 01/2002
33	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 11/2003
24	hydroxide ionIBA 01/2024 - 06/2003
19	alpha-SynucleinIBA 03/2024 - 04/2004
17	Biomarkers (Surrogate Marker)IBA 12/2022 - 02/2007
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2005
11	SynucleinsIBA 02/2024 - 04/2004
9	Epinephrine (Adrenaline)FDA LinkGeneric 09/2008 - 01/2003
7	3,4-dihydroxyphenylacetaldehydeIBA 06/2021 - 12/2012
6	Neurotransmitter Agents (Neurotransmitter)IBA 10/2020 - 11/2002
6	CatecholsIBA 01/2019 - 06/2003
6	CopperIBA 09/2018 - 02/2008
5	TyramineIBA 02/2016 - 10/2004
5	3,4-dihydroxyphenylglycolIBA 01/2010 - 11/2004
5	NormetanephrineIBA 04/2005 - 01/2003
4	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2022 - 12/2004
4	Aldehyde DehydrogenaseIBA 01/2022 - 08/2014
4	3,4-Dihydroxyphenylacetic AcidIBA 01/2018 - 08/2009
4	Dihydroxyphenylalanine (Dopa)IBA 09/2015 - 08/2004
4	Messenger RNA (mRNA)IBA 01/2015 - 10/2005
4	Levodopa (L Dopa)FDA LinkGeneric 10/2014 - 11/2003
4	MetanephrineIBA 04/2005 - 01/2003
3	catechol (pyrocatechol)IBA 02/2024 - 12/2004
3	Cholinergic Agents (Cholinergics)IBA 12/2023 - 10/2004
3	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2022 - 03/2003
3	Monoamine Oxidase (MAO)IBA 11/2017 - 02/2016
3	EnzymesIBA 01/2016 - 08/2003
3	Edrophonium (Tensilon)FDA LinkGeneric 05/2015 - 10/2004
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2013 - 05/2002
3	Glucagon (Glukagon)FDA Link 01/2010 - 09/2008
3	Yohimbine (Yocon)IBA 11/2008 - 07/2002
3	Aromatic-L-Amino-Acid DecarboxylasesIBA 12/2004 - 03/2003
3	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2003 - 06/2002
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2022 - 10/2005
2	RotenoneIBA 01/2022 - 04/2015
2	VaccinesIBA 01/2020 - 01/2020
2	DroxidopaIBA 01/2019 - 05/2010
2	Selegiline (E250)FDA LinkGeneric 11/2017 - 09/2016
2	AldehydesIBA 03/2015 - 01/2012
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 07/2014 - 09/2003
2	Adenosine Triphosphatases (ATPase)IBA 02/2013 - 05/2002
2	Copper-Transporting ATPasesIBA 09/2012 - 08/2009
2	Transcription Factors (Transcription Factor)IBA 07/2012 - 08/2006
2	fluorodopa F 18IBA 11/2011 - 01/2010
2	ProdrugsIBA 01/2011 - 05/2010
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2009 - 03/2009
2	AntibodiesIBA 03/2009 - 12/2006
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2008 - 09/2008
2	Trimethaphan (Trimetaphan)IBA 11/2008 - 10/2004
2	AminesIBA 04/2005 - 01/2003
2	Amino Acids FDA Link 12/2004 - 08/2003
2	FludrocortisoneIBA 08/2003 - 11/2002
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 05/2024
1	SCH 23390IBA 09/2022
1	CytokinesIBA 01/2022

Therapy/Procedure

25	Sympathectomy (Sympathectomies) 01/2019 - 08/2002
17	Denervation 01/2019 - 09/2003
5	Therapeutics 03/2022 - 08/2003
1	Diskectomy (Discectomy) 05/2024
1	Self Administration (Administration, Self) 09/2022